Patient NAME : Ms SONIA GOEL

DOB/Age/Gender : 43 Y/Female Report STATUS : Final Report

Patient ID / UHID : 12524160/RCL11896900 Barcode NO : 25418622
Referred BY : Self Sample Type : Whole blood EDTA
....

Sample Collected : May 23, 2025, 07:37 AM Report Date : May 23, 2025, 01:03 PM.
Test Description Value(s) Unit(s) Reference Range

Visit - Star Health - Package 7

Complete Blood Count (CBC)

RBC Parameters
Hemoglobin 11.8 g/dL 12.0 - 15.0
colorimetric
RBC Count 5.2 10^6/µl 3.8 - 4.8
Electrical impedance
PCV 40.1 % 36 - 46
Calculated
MCV 77 fl 83 - 101
Calculated
MCH 22.6 pg 27 - 32
Calculated
MCHC 29.4 g/dL 31.5 - 34.5
Calculated
RDW (CV) * 16.9 % 11.6 - 14.0
Calculated
RDW-SD * 45.9 fl 35.1 - 43.9
Calculated
WBC Parameters
TLC 10.2 10^3/µl 4 - 10
Electrical impedance and microscopy
Differential Leucocyte Count
Neutrophils 50 % 40-80
Lymphocytes 44 % 20-40
Monocytes 4 % 2-10
Eosinophils 2 % 1-6
Basophils 0 % <2
Absolute Leukocyte Counts
Calculated
Neutrophils. 5.1 10^3/µl 2-7
Lymphocytes. 4.49 10^3/µl 1-3
Monocytes. 0.41 10^3/µl 0.2 - 1.0
Eosinophils. 0.2 10^3/µl 0.02 - 0.5
Basophils. 0 10^3/µl 0.02 - 0.5
Platelet Parameters
Platelet Count 215 10^3/µl 150 - 410
Electrical impedance and microscopy
Mean Platelet Volume (MPV) * 12.4 fL 9.3 - 12.1
Calculated
PCT * 0.3 % 0.17 - 0.32
Calculated
(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Visit Noida, .

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., House No.2, Sarvodaya Nagar, Bareilly, Uttar Pradesh-243001

Page 1 of 18
 Patient NAME : Ms SONIA GOEL
DOB/Age/Gender : 43 Y/Female Report STATUS : Final Report
Patient ID / UHID : 12524160/RCL11896900 Barcode NO : 25418622
Referred BY : Self Sample Type : Whole blood EDTA
Sample Collected : May 23, 2025, 07:37 AM Report Date : May 23, 2025, 01:03 PM.
Test Description Value(s) Unit(s) Reference Range
PDW * 17.2 fL 8.3 - 25.0
Calculated
P-LCR * 46.6 % 18 - 50
Calculated
P-LCC * 100 10^9/L 44 - 140
Calculated
Mentzer Index * 14.81 % > 13
Calculated

Interpretation:
CBC provides information about red cells, white cells and platelets. Results are useful in the diagnosis of anemia, infections, leukemias, clotting disorders and many
other medical conditions.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Visit Noida, .

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., House No.2, Sarvodaya Nagar, Bareilly, Uttar Pradesh-243001

Page 2 of 18
 Patient NAME : Ms SONIA GOEL
DOB/Age/Gender : 43 Y/Female Report STATUS : Final Report
Patient ID / UHID : 12524160/RCL11896900 Barcode NO : 25418622
Referred BY : Self Sample Type : Whole blood EDTA
....

Sample Collected : May 23, 2025, 07:37 AM Report Date : May 23, 2025, 02:06 PM.
Test Description Value(s) Unit(s) Reference Range

Erythrocyte Sedimentation Rate (ESR)

ESR - Erythrocyte Sedimentation Rate 22 mm/hr 0 - 12

MODIFIED WESTERGREN

Interpretation:
ESR is also known as Erythrocyte Sedimentation Rate. An ESR test is used to assess inflammation in the body. Many conditions can cause
an abnormal ESR, so an ESR test is typically used with other tests to diagnose and monitor different diseases. An elevated ESR may occur in
inflammatory conditions including infection, rheumatoid arthritis ,systemic vasculitis, anemia, multiple myeloma , etc. Low levels are typically
seen in congestive heart failure, polycythemia ,sickle cell anemia, hypo fibrinogenemia , etc.

Reference- Dacie and lewis practical hematology

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Visit Noida, .

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., House No.2, Sarvodaya Nagar, Bareilly, Uttar Pradesh-243001

Page 3 of 18
 Patient NAME : Ms SONIA GOEL
DOB/Age/Gender : 43 Y/Female Report STATUS : Final Report
Patient ID / UHID : 12524160/RCL11896900 Barcode NO : 25418622
Referred BY : Self Sample Type : Whole blood EDTA
....

Sample Collected : May 23, 2025, 07:37 AM Report Date : May 23, 2025, 03:08 PM.
Test Description Value(s) Unit(s) Reference Range

HbA1C (Glycosylated Haemoglobin)

Glycosylated Hemoglobin (HbA1c) 6.7 % <5.7

turbidimetric inhibition immunoassay (TINIA)
Estimated Average Glucose * 145.59 mg/dL Refer Table Below

Interpretation:
Interpretation For HbA1c% As per American Diabetes Association (ADA)
Reference Group HbA1c in %
Non diabetic adults >=18 years <5.7
At risk (Prediabetes) 5.7 - 6.4
Diagnosing Diabetes >= 6.5
Age > 19 years
Goal of therapy: < 7.0
Therapeutic goals for glycemic control
Age < 19 years
Goal of therapy: <7.5

Note:
1. Since HbA1c reflects long term fluctuations in the blood glucose concentration, a diabetic patient who is recently under good control may still have a high
concentration of HbA1c. Converse is true for a diabetic previously under good control but now poorly controlled.
2. Target goals of < 7.0 % may be beneficial in patients with short duration of diabetes, long life expectancy and no significant cardiovascular disease. In patients with
significant complications of diabetes, limited life expectancy or extensive co-morbid conditions, targeting a goal of < 7.0 % may not be appropriate.

Comments :
HbA1c provides an index of average blood glucose levels over the past 8 - 12 weeks and is a much better indicator of long term glycemic control as compared to blood
and urinary glucose determinations ADA criteria for correlation between HbA1c & Mean plasma glucose levels.
HbA1c(%) Mean Plasma Glucose (mg/dL) HbA1c(%) Mean Plasma Glucose (mg/dL)
6 126 12 298
8 183 14 355
10 240 16 413

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Visit Noida, .

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., House No.2, Sarvodaya Nagar, Bareilly, Uttar Pradesh-243001

Page 4 of 18
 Patient NAME : Ms SONIA GOEL
DOB/Age/Gender : 43 Y/Female Report STATUS : Final Report
Patient ID / UHID : 12524160/RCL11896900 Barcode NO : 25836925
Referred BY : Self Sample Type : FLUORIDE F
....

Sample Collected : May 23, 2025, 07:37 AM Report Date : May 23, 2025, 03:08 PM.
Test Description Value(s) Unit(s) Reference Range

Glucose Fasting

Glucose Fasting 124.7 mg/dL 70 - <100

Hexokinase

Interpretation:
Status Fasting plasma glucose in mg/dL
Normal 70 - 100
Impaired fasting glucose 101 - 125
Diabetes ≥126

Reference : American Diabetes Association

Comment :
Blood glucose determinations in commonly used as an aid in the diagnosis and treatment of diabetes. Elevated glucose levels
(hyperglycemia) may also occur with pancreatic neoplasm, hyperthyroidism, and adrenal cortical hyper function as well as other disorders.
Decreased glucose levels (hypoglycemia) may result from excessive insulin therapy insulinoma, or various liver diseases.

Note
1.The diagnosis of Diabetes requires a fasting plasma glucose of > or = 126 mg/dL or a random / 2 hour plasma glucose value of > or = 200
mg/dL with symptoms of diabetes mellitus.
2.Very high glucose levels (>450 mg/dL in adults) may result in Diabetic Ketoacidosis.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Visit Noida, .

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., House No.2, Sarvodaya Nagar, Bareilly, Uttar Pradesh-243001

Page 5 of 18
 Patient NAME : Ms SONIA GOEL
DOB/Age/Gender : 43 Y/Female Report STATUS : Final Report
Patient ID / UHID : 12524160/RCL11896900 Barcode NO : 25209202
Referred BY : Self Sample Type : Serum
....

Sample Collected : May 23, 2025, 07:38 AM Report Date : May 23, 2025, 03:51 PM.
Test Description Value(s) Unit(s) Reference Range

Blood Urea Nitrogen (Bun)

Blood Urea 30 mg/dL 16.6 - 48.5

Urease
Bun * 14.02 mg/dL 6 - 20
Urease

Interpretation:
1. The blood urea nitrogen (BUN) test measures the amount of nitrogen in your blood that comes from the waste product urea. Urea is formed
in the liver when the body breaks down proteins and is eventually eliminated by the kidneys.

2. Low BUN levels can be caused by a variety of factors. Liver disease is a primary cause, as urea is produced in the liver, and any dysfunction
in this organ can lead to lower BUN levels. Malnutrition or a low protein diet can also contribute, as inadequate protein intake reduces urea
production. Overhydration, resulting from excessive fluid intake, can dilute the urea concentration in the blood. Additionally, pregnancy can
lower BUN levels due to increased fluid retention and changes in metabolism.

3. High BUN levels can result from various conditions. Kidney dysfunction is a primary cause, as impaired kidney function can reduce urea
elimination. Dehydration, which decreases fluid volume in the body, can also concentrate urea. A high protein diet can increase urea
production due to excessive protein intake. Heart failure can reduce blood flow to the kidneys, impairing their function. Gastrointestinal
bleeding contributes to high BUN levels by breaking down blood proteins in the digestive tract. Certain medications, such as corticosteroids
and antibiotics, can elevate BUN levels. Additionally, shock or severe stress can affect BUN levels by reducing blood flow to the kidneys.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Visit Noida, .

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., House No.2, Sarvodaya Nagar, Bareilly, Uttar Pradesh-243001

Page 6 of 18
 Patient NAME : Ms SONIA GOEL
DOB/Age/Gender : 43 Y/Female Report STATUS : Final Report
Patient ID / UHID : 12524160/RCL11896900 Barcode NO : 25209202
Referred BY : Self Sample Type : Serum
....

Sample Collected : May 23, 2025, 07:38 AM Report Date : May 23, 2025, 03:51 PM.
Test Description Value(s) Unit(s) Reference Range

Creatinine

Creatinine 0.6 mg/dL 0.50 - 0.90

Jaffe
eGFR (CKD-EPI) 114.12 ml/min/1.73 sq m Normal Or High: >= 90

Mild Or Decrease: 60-89

Mild To Moderate Decrease:

45-59

Mild To Severe Decrease:

30-44

Severe Decrease: 15-29

Kidney Failure: < 15

Interpretation:
Creatinine estimation is done to assess kidney function. It is not dependent on dietary factors. Normal values are obtained in kidney diseases,
except in advanced renal failure and therefore its estimation is more valuable if coupled with clearance.

"eGFR test is applicable for patients aged 18 years or more."

Uric Acid

Uric Acid 6 mg/dL 2.4 - 5.7

Enzymatic colorimetric

Interpretation:
Serum uric acid levels are very labile and show day to day and seasonal variation in some people. Levels are also increased by emotional stress, total fasting and
increased body weight. Serum uric acid levels are used to diagnose and monitor treatment of gout, monitor chemotherapeutic treatment of neoplasms to avoid renal
urate deposition with possible renal failure.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Visit Noida, .

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., House No.2, Sarvodaya Nagar, Bareilly, Uttar Pradesh-243001

Page 7 of 18
 Patient NAME : Ms SONIA GOEL
DOB/Age/Gender : 43 Y/Female Report STATUS : Final Report
Patient ID / UHID : 12524160/RCL11896900 Barcode NO : 25209202
Referred BY : Self Sample Type : Serum
....

Sample Collected : May 23, 2025, 07:38 AM Report Date : May 23, 2025, 03:51 PM.
Test Description Value(s) Unit(s) Reference Range

Liver Function Test (LFT)

Bilirubin Total 0.1 mg/dL 0 - 1.2

Colorimetric Diazo
Bilirubin Direct * 0.1 mg/dL 0 - 0.5
Bilirubin Indirect * 0 mg/dL 0.1 - 1.0
Calculation (T Bil - D Bil)
SGOT/AST 34.2 U/L up to 40
IFCC without P5P
SGPT/ALT 44.3 U/L up to 41
IFCC without P5P
SGOT/SGPT Ratio * 0.77 - -
Alkaline Phosphatase 113 U/L 35 - 104
IFCC
Total Protein 7.3 g/dL 6.0 - 7.8
Biuret
Albumin 4.2 g/dL 3.5 - 5.2
Colorimetric
Globulin * 3.1 g/dL 2.3 - 3.5
Calculation (T.P - Albumin)
Albumin :Globulin Ratio * 1.35 - 1.0 - 2.1
Calculation (Albumin/Globulin)
Gamma Glutamyl Transferase (GGT) * 23 U/L 5-40
ENZYMATIC

Interpretation:
The liver filters blood, metabolizes nutrients, detoxifies harmful substances, and produces blood clotting proteins. Liver cells contain enzymes that facilitate
these functions. When cells are damaged, enzymes leak into the blood, detectable through blood tests.

Key enzymes tested:

1. AST (SGOT): may indicate tissue injury / damage in muscles or liver.

2. ALT (SGPT): Primarily in the liver. Elevated ALT and AST suggest liver damage.
3. Alkaline Phosphatase & GGT: Linked to bile production and flow. Elevated levels may indicate bile flow issues related to the liver, gallbladder, or bile ducts.

Blood proteins, albumin and globulin, are essential for growth, development, and health.

1. Low protein: May indicate bleeding, liver disorders, malnutrition, or agammaglobulinemia.

2. High protein (Hyperproteinemia): Often due to dehydration or increased protein production.
3. Low albumin: Caused by poor diet, kidney, or liver disease.
4. High albumin: Usually due to severe dehydration.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Visit Noida, .

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., House No.2, Sarvodaya Nagar, Bareilly, Uttar Pradesh-243001

Page 8 of 18
 Patient NAME : Ms SONIA GOEL
DOB/Age/Gender : 43 Y/Female Report STATUS : Final Report
Patient ID / UHID : 12524160/RCL11896900 Barcode NO : 25209202
Referred BY : Self Sample Type : Serum
....

Sample Collected : May 23, 2025, 07:38 AM Report Date : May 23, 2025, 03:51 PM.
Test Description Value(s) Unit(s) Reference Range

Lipid Profile

Total Cholesterol 163.5 mg/dL <200

Enzymatic - Cholesterol Oxidase
Triglycerides 325.2 mg/dL <150
Colorimetric - Lip/Glycerol Kinase
HDL Cholesterol 33.5 mg/dL >55
Enzymatic colorimetric
Non HDL Cholesterol * 130 mg/dL <130
Calculated
LDL Cholesterol * 64.96 mg/dL <100
Calculated
V.L.D.L Cholesterol * 65.04 mg/dL < 30
Calculated
Chol/HDL Ratio * 4.88 Ratio 3.5 - 5.0
Calculated
HDL/ LDL Ratio * 0.52 Ratio 0.5 - 3.0
Calculated
LDL/HDL Ratio * 1.94 Ratio -
Calculated

Interpretation:
Lipid level assessments must be made following 9 to 12 hours of fasting, otherwise assay results might lead to erroneous interpretation. NCEP recommends of 3
different samples to be drawn at intervals of 1 week for harmonizing biological variables that might be encountered in single assays.

National Lipid Association Recommendations Total Cholesterol Triglyceride LDL Cholesterol Non HDL Cholesterol
(NLA-2014) (mg/dL) (mg/dL) (mg/dL) (mg/dL)
Optimal <200 <150 <100 <130

Above Optimal 100-129 130 - 159

Borderline High 200-239 150-199 130-159 160 - 189
High >=240 200-499 160-189 190 - 219
Very High - >=500 >=190 >=220

HDL Cholesterol
Low High
<40 >=60

Risk Stratification for ASCVD (Atherosclerotic Cardiovascular Disease) by Lipid Association of India.

Risk Category A. CAD with > 1 feature of high risk group

B. CAD with >1 feature of very high risk group of recurrent ACS (within 1 year) despite LDL-C <or = 50 mg/dl
Extreme risk group
or poly vascular disease
1.Established ASCVD 2.Diabetes with 2 major risk factors of evidence of end organ
Very High Risk
damage 3. Familial Homozygous Hypercholesterolemia
1. Three major ASCVD risk factors 2. Diabetes with 1 major risk factor or no evidence

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Visit Noida, .

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., House No.2, Sarvodaya Nagar, Bareilly, Uttar Pradesh-243001

Page 9 of 18
 Patient NAME : Ms SONIA GOEL
DOB/Age/Gender : 43 Y/Female Report STATUS : Final Report
Patient ID / UHID : 12524160/RCL11896900 Barcode NO : 25209202
Referred BY : Self Sample Type : Serum
Sample Collected : May 23, 2025, 07:38 AM Report Date : May 23, 2025, 03:51 PM.
Test Description Value(s) Unit(s) Reference Range
of end organ damage 3. CHD stage 3B or 4. 4 LDL >190 mg/dl 5. Extreme of a single
High Risk
risk factor 6. Coronary Artery Calcium - CAC > 300 AU 7. Lipoprotein a >/= 50 mg/dl
8. Non stenotic carotid plaque
Moderate Risk 2 major ASCVD risk factors
Low Risk 0-1 major ASCVD risk factors
Major ASCVD (Atherosclerotic cardiovascular disease) Risk Factors
1. Age >/=45 years in Males &
3. Current Cigarette smoking or tobacco use
>/= 55 years in Females
2. Family history of premature
4. High blood pressure
ASCVD
5. Low HDL

Newer treatment goals and statin initiation thresholds based on the risk categories proposed by Lipid Association of India
in 2020.

Risk Group Treatment Goals Consider Drug Therapy

LDL-C (mg/dl) Non-HDL (mg/dl) LDL-C (mg/dl) Non-HDL (mg/dl)

Extreme Risk Group Category A <50 (Optional goal <OR = 30) <80 (Optional goal <OR = 60) >OR = 50 >OR = 80
Extreme Risk Group Category B >OR = 30 >OR = 60 > 30 > 60
Very High Risk <50 <80 >OR = 50 >OR = 80
High Risk <70 <100 >OR = 70 >OR = 100
Moderate Risk <100 <130 >OR = 100 >OR = 130
Low Risk <100 <130 >OR = 130* >OR = 160

* After an adequate non-pharmacological intervention for at least 3 months.

References : Management of Dyslipidaemia for the Prevention of Stroke : Clinical practice Recommendations from the Lipid Association of
India. Current Vascular Pharmacology,2022,20,134-155.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Visit Noida, .

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., House No.2, Sarvodaya Nagar, Bareilly, Uttar Pradesh-243001

Page 10 of 18
 Patient NAME : Ms SONIA GOEL
DOB/Age/Gender : 43 Y/Female Report STATUS : Final Report
Patient ID / UHID : 12524160/RCL11896900 Barcode NO : 25209202
Referred BY : Self Sample Type : Serum
....

Sample Collected : May 23, 2025, 07:38 AM Report Date : May 23, 2025, 03:51 PM.
Test Description Value(s) Unit(s) Reference Range

Calcium

Calcium Serum 9.1 mg/dL 8.6 - 10.0

BAPTA

Interpretation:
Elevated calcium value are associated with hyperparathyrodism, multiple myeloma, neoplasms of bone and parathyroid & conditions of rapid
demineralization, tetany & occasionally with nephrosis & pancreatitis. Severe nephritis & uremia may cause either elevated or lowered calcium
values. Decreased values of calcium are noted in hypoparathyroidism, vitamin D deficiency, renal insufficiency, hypoproteinemia,
malabsorption syndrome, severe pancreatitis with pancreatic necrosis and pseudo-hypoparathyroidism.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Visit Noida, .

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., House No.2, Sarvodaya Nagar, Bareilly, Uttar Pradesh-243001

Page 11 of 18
 Patient NAME : Ms SONIA GOEL
DOB/Age/Gender : 43 Y/Female Report STATUS : Final Report
Patient ID / UHID : 12524160/RCL11896900 Barcode NO : 25209202
Referred BY : Self Sample Type : Serum
....

Sample Collected : May 23, 2025, 07:38 AM Report Date : May 24, 2025, 10:44 AM.
Test Description Value(s) Unit(s) Reference Range

Lipase

Lipase 30.7 U/L 13 - 60

Colorimetric

Interpretation:
Pancreas is the major and primary source of serum lipase though lipases are also present in liver, stomach, intestine, WBC, fat cells and milk. In acute pancreatitis,
serum lipase becomes elevated at the same time as amylase and remains high for 7-10 days. Increased
lipase activity rarely lasts longer than 14 days. Prolonged increase suggests poor prognosis or presence of a cyst. The combined use of serum lipase and serum amylase
is effective in ruling out acute pancreatitis.

Increased levels
Acute & Chronic pancreatitis
Obstruction of pancreatic duct
Non pancreatic conditions like renal diseases, acute cholecystitis, intestinal obstruction, duodenal ulcer, alcoholism, diabetic ketoacidosis and following endoscopic
retrograde cholangiopancreatography

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Visit Noida, .

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., H-55, Sector-63, Noida, Uttar Pradesh - 201301

Page 12 of 18
 Patient NAME : Ms SONIA GOEL
DOB/Age/Gender : 43 Y/Female Report STATUS : Final Report
Patient ID / UHID : 12524160/RCL11896900 Barcode NO : 25209202
Referred BY : Self Sample Type : Serum
....

Sample Collected : May 23, 2025, 07:38 AM Report Date : May 24, 2025, 10:44 AM.
Test Description Value(s) Unit(s) Reference Range

Amylase

Amylase 44.9 U/L 28 - 100

Enzymatic colorimetric

Interpretation:
1. Amylase levels are significantly increased in patients with acute pancreatitis, pancreatic duct obstruction, carcinoma pancreas, ovaries, or lungs, cholecystitis,
macroamylasemia, renal disease, pancreatic pseudocyst, procedures like Endoscopic retrograde cholangiopancreatography and acute alcohol poisoning.
2. In acute pancreatitis, elevated amylase levels usually parallel lipase concentrations, although lipase levels may take a bit longer to rise than blood amylase
levels and will remain elevated longer.
3. Amylase levels are raised in aspirin, diuretics, oral contraceptives, corticosteroids, indomethacin, ethyl alcohol and opiate intake

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Visit Noida, .

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., H-55, Sector-63, Noida, Uttar Pradesh - 201301

Page 13 of 18
 Patient NAME : Ms SONIA GOEL
DOB/Age/Gender : 43 Y/Female Report STATUS : Final Report
Patient ID / UHID : 12524160/RCL11896900 Barcode NO : 25209202
Referred BY : Self Sample Type : Serum
....

Sample Collected : May 23, 2025, 07:38 AM Report Date : May 23, 2025, 01:52 PM.
Test Description Value(s) Unit(s) Reference Range

Vitamin D 25 Hydroxy

Vitamin D 25 - Hydroxy 13 ng/mL Deficiency : < 10 ng/mL

ECLIA Insufficient : 10-30 ng/mL
Sufficient : 30-100 ng/mL
Hypervitaminosis : > 100
ng/mL

Interpretation:
25-Hydroxy vitamin D represents the main body reservoir and transport form. Mild to moderate deficiency is associated with Osteoporosis /
Secondary Hyperparathyroidism while severe deficiency causes Rickets in children and Osteomalacia in adults. Prevalence of Vitamin D
deficiency is approximately >50% specially in the elderly. This assay is useful for diagnosis of vitamin D deficiency and Hypervitaminosis D. It
is also used for differential diagnosis of causes of Rickets & Osteomalacia and for monitoring Vitamin D replacement therapy.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Visit Noida, .

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., House No.2, Sarvodaya Nagar, Bareilly, Uttar Pradesh-243001

Page 14 of 18
 Patient NAME : Ms SONIA GOEL
DOB/Age/Gender : 43 Y/Female Report STATUS : Final Report
Patient ID / UHID : 12524160/RCL11896900 Barcode NO : 25209202
Referred BY : Self Sample Type : Serum
....

Sample Collected : May 23, 2025, 07:38 AM Report Date : May 23, 2025, 01:52 PM.
Test Description Value(s) Unit(s) Reference Range

FT3 (Free Triiodothyronine 3)

T3, Free 2.7 pg/mL 1.4 - 4.4

ECLIA
Pregnancy : 2.0 - 3.8
Interpretation:
1. Triiodothyronine (T3) is one of the two primary thyroid hormones the thyroid gland produces, along with thyroxine (T4). T3 regulates
metabolism, energy production, growth, and development throughout the body.

2. Free T3 refers to the portion of T3 that is unbound to proteins in the blood and is considered the active form of the hormone. It represents
the fraction of T3 available for cellular uptake and metabolic activity.

3. The free T3 blood test assesses thyroid function and diagnoses thyroid disorders, such as hyperthyroidism (overactive thyroid) or
hypothyroidism (underactive thyroid). It provides valuable information about the body&#39;s metabolic rate and thyroid hormone status.

FT4 (Free Thyroxine 4)

T4, Free 1.19 ng/dL 0.8 - 1.8

ECLIA
First Trimester : 0.7-2.0

Second Trimester : 0.5-1.6

Third Trimester : 0.5-1.6

Interpretation:
1. Free T4 is the unbound and active form of thyroxine, a hormone produced by the thyroid gland that helps regulate metabolism, energy
production, and overall growth and development. Interpreting free T4 levels helps diagnose thyroid function disorders.

2. Low free T4 levels, indicative of hypothyroidism, can result from several causes. Primary hypothyroidism occurs when the thyroid gland itself
is underactive, often due to Hashimoto's thyroiditis, iodine deficiency, or thyroid surgery. Secondary hypothyroidism arises when the pituitary
gland fails to produce sufficient thyroid-stimulating hormone (TSH) to activate the thyroid, commonly due to pituitary disorders. Tertiary
hypothyroidism is caused by the hypothalamus failing to produce enough thyrotropin-releasing hormone (TRH), which leads to decreased
production of TSH and subsequently T4.

3. High free T4 levels, indicative of hyperthyroidism, can be caused by various conditions. Graves' disease, an autoimmune disorder,
overstimulates the thyroid gland, leading to excessive hormone production. Overactive thyroid nodules can also contribute to high free T4
levels by producing excess hormone independently. Thyroiditis, an inflammation of the thyroid, can release stored hormones into the
bloodstream, causing elevated levels. Overmedication with thyroid hormone replacement can also result in high free T4 levels.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Visit Noida, .

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., House No.2, Sarvodaya Nagar, Bareilly, Uttar Pradesh-243001

Page 15 of 18
 Patient NAME : Ms SONIA GOEL
DOB/Age/Gender : 43 Y/Female Report STATUS : Final Report
Patient ID / UHID : 12524160/RCL11896900 Barcode NO : 25209202
Referred BY : Self Sample Type : Serum
Sample Collected : May 23, 2025, 07:38 AM Report Date : May 23, 2025, 01:52 PM.
Test Description Value(s) Unit(s) Reference Range

TSH 3rd Generation

Thyroid Stimulating Hormone (Ultrasensitive) 8 mIU/L 0.35 - 4.94

CMIA

Interpretation:
Pregnancy Reference ranges TSH
1 st Trimester 0.1 - 2.5
2 ed Trimester 0.2 - 3.0
3 rd Trimester 0.3 - 3.0

Note:
TSH levels are subject to circadian variation, reaching peak levels between 2-4 am. and at a minimum between 6-10 pm. The variation is of 50 %, hence time of the
day has influence on the measured serum TSH concentrations.

Clinical Use:
- Diagnose Hypothyroidism and Hyperthyroidism
- Monitor T4 replacement or T4 suppressive therapy
- Qunatify TSH levels in the subnormal range

Increased Levels : Primary hypothyroidism, Subclinical hypothyroidis, TSH dependent Hyperthyroidism, Thyroid hormone resistance
Decreased Levels: Grace disease, Autonomous thyroid hormone secretion, TSH deficiency

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Visit Noida, .

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., House No.2, Sarvodaya Nagar, Bareilly, Uttar Pradesh-243001

Page 16 of 18
 Patient NAME : Ms SONIA GOEL
DOB/Age/Gender : 43 Y/Female Report STATUS : Final Report
Patient ID / UHID : 12524160/RCL11896900 Barcode NO : 25209202
Referred BY : Self Sample Type : Serum
....

Sample Collected : May 23, 2025, 07:38 AM Report Date : May 23, 2025, 04:23 PM.
Test Description Value(s) Unit(s) Reference Range

Electrolytes (Na/K/Cl)

Sodium 141 mmol/L 136 - 145

ISE-Indirect
Potassium 4.2 mmol/L 3.5 - 5.1
ISE-Indirect
Chloride 103.7 mmol/L 98 - 107
Potentiometric

Interpretation:
An electrolyte panel, which typically includes measurements of sodium (Na), potassium (K), and chloride (Cl) levels, is a common blood test
that provides information about your body's electrolyte balance.

1. Sodium (Na):
1. Sodium is crucial in maintaining fluid balance in your body and is essential for nerve function and muscle contraction.
2. High sodium levels (hypernatremia) or low sodium levels (hyponatremia) can indicate various health conditions, including dehydration,
kidney problems, or hormonal imbalances.

2. Potassium (K):
1. Potassium is vital for proper muscle function, including the heart muscle and nerve function, as well as maintaining fluid and electrolyte
balance.
2. Abnormal potassium levels (hyperkalemia or hypokalemia) can indicate kidney dysfunction, dehydration, certain medications, or other
underlying health issues.

3. Chloride (Cl):
1. Chloride works closely with sodium and potassium to maintain fluid balance and proper pH levels in the body.
2. Abnormal chloride levels may occur alongside imbalances in sodium and potassium and can indicate dehydration, kidney problems,
respiratory issues, or metabolic disorders.

Healthcare providers typically order an electrolyte panel to evaluate and monitor electrolyte imbalances, diagnose certain medical conditions,
assess kidney function, or monitor treatment effectiveness. It's usually part of routine blood testing, especially in cases of dehydration, kidney
disease, heart conditions, or electrolyte disorders.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Visit Noida, .

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., House No.2, Sarvodaya Nagar, Bareilly, Uttar Pradesh-243001

Page 17 of 18
 Patient NAME : Ms SONIA GOEL
DOB/Age/Gender : 43 Y/Female Report STATUS : Final Report
Patient ID / UHID : 12524160/RCL11896900 Barcode NO : 25209202
Referred BY : Self Sample Type : Serum
....

Sample Collected : May 23, 2025, 07:38 AM Report Date : May 24, 2025, 11:42 AM.
Test Description Value(s) Unit(s) Reference Range

Hepatitis B Surface Antibodies (HBsAb)

Hepatitis B surface Antibody, Anti Hbs <2.00 IU/L > 10

ECLIA

Interpretation:
Reference range is defined as per CLSI guidelines and WHO International Standard for Anti-HBs
Interpretation :

RESULT IN IU/L REMARKS INTERPRETATION

<10 Non-Reactive Indicates absence of antibodies to Hepatitis B Surface antigen.

>=10 Reactive Indicates presence of antibodies to Hepatitis B Surface antigen.

Note :
1. Reactive test result indicates presence of antibodies to Hepatitis B Surface Antigen. Detection of Anti-HBs antibodies is observed in recent Hepatitis B viral infection, resolved Hepatitis B viral infection and after successful HBV
vaccination.
2. This assay does not differentiate between a vaccine induced immune response and an immune response induced by infection with HBV.
3. Non-Reactive test result indicates absence of antibodies to Hepatitis B Surface Antigen.
4. False positive results may be observed in patients receiving mouse monoclonal antibodies, on heparin therapy, on biotin supplements for diagnosis or therapy, presence of heterophilic antibodies in serum.
5. False negative reaction may be due to processing of sample collected early in the course of disease, presence of mutant forms of HBsAg and immunocompromised / immunosuppressed conditions.
6. Test conducted on serum.
Uses :
1. To determine immune status to HBV or disease progression in individuals infected with HBV
2. To determine if vaccination is needed
3. To determine if protective immunity has been achieved following a vaccination regimen.

*** End Of Report ***

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Visit Noida, .

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., H-55, Sector-63, Noida, Uttar Pradesh - 201301

Page 18 of 18
 HOW WAS YOUR EXPERIENCE?
We value your feedback, please scan with your phone camera
and rate overall experience.

How likely are you to recommend Redcliffe Labs to your family & friends

Not Likely Very Likely

Scan with your phone camera